Cargando…
Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease
Preeclampsia is a multifactorial cardiovascular disorder diagnosed after 20 weeks of gestation, and is the leading cause of death for both mothers and babies in pregnancy. The pathophysiology remains poorly understood due to the variability and unpredictability of disease manifestation when studied...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070848/ https://www.ncbi.nlm.nih.gov/pubmed/33919808 http://dx.doi.org/10.3390/cells10040899 |
_version_ | 1783683566064893952 |
---|---|
author | Liu Chung Ming, Clara Sesperez, Kimberly Ben-Sefer, Eitan Arpon, David McGrath, Kristine McClements, Lana Gentile, Carmine |
author_facet | Liu Chung Ming, Clara Sesperez, Kimberly Ben-Sefer, Eitan Arpon, David McGrath, Kristine McClements, Lana Gentile, Carmine |
author_sort | Liu Chung Ming, Clara |
collection | PubMed |
description | Preeclampsia is a multifactorial cardiovascular disorder diagnosed after 20 weeks of gestation, and is the leading cause of death for both mothers and babies in pregnancy. The pathophysiology remains poorly understood due to the variability and unpredictability of disease manifestation when studied in animal models. After preeclampsia, both mothers and offspring have a higher risk of cardiovascular disease (CVD), including myocardial infarction or heart attack and heart failure (HF). Myocardial infarction is an acute myocardial damage that can be treated through reperfusion; however, this therapeutic approach leads to ischemic/reperfusion injury (IRI), often leading to HF. In this review, we compared the current in vivo, in vitro and ex vivo model systems used to study preeclampsia, IRI and HF. Future studies aiming at evaluating CVD in preeclampsia patients could benefit from novel models that better mimic the complex scenario described in this article. |
format | Online Article Text |
id | pubmed-8070848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80708482021-04-26 Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease Liu Chung Ming, Clara Sesperez, Kimberly Ben-Sefer, Eitan Arpon, David McGrath, Kristine McClements, Lana Gentile, Carmine Cells Review Preeclampsia is a multifactorial cardiovascular disorder diagnosed after 20 weeks of gestation, and is the leading cause of death for both mothers and babies in pregnancy. The pathophysiology remains poorly understood due to the variability and unpredictability of disease manifestation when studied in animal models. After preeclampsia, both mothers and offspring have a higher risk of cardiovascular disease (CVD), including myocardial infarction or heart attack and heart failure (HF). Myocardial infarction is an acute myocardial damage that can be treated through reperfusion; however, this therapeutic approach leads to ischemic/reperfusion injury (IRI), often leading to HF. In this review, we compared the current in vivo, in vitro and ex vivo model systems used to study preeclampsia, IRI and HF. Future studies aiming at evaluating CVD in preeclampsia patients could benefit from novel models that better mimic the complex scenario described in this article. MDPI 2021-04-14 /pmc/articles/PMC8070848/ /pubmed/33919808 http://dx.doi.org/10.3390/cells10040899 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Liu Chung Ming, Clara Sesperez, Kimberly Ben-Sefer, Eitan Arpon, David McGrath, Kristine McClements, Lana Gentile, Carmine Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease |
title | Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease |
title_full | Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease |
title_fullStr | Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease |
title_full_unstemmed | Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease |
title_short | Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease |
title_sort | considerations to model heart disease in women with preeclampsia and cardiovascular disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070848/ https://www.ncbi.nlm.nih.gov/pubmed/33919808 http://dx.doi.org/10.3390/cells10040899 |
work_keys_str_mv | AT liuchungmingclara considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease AT sesperezkimberly considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease AT bensefereitan considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease AT arpondavid considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease AT mcgrathkristine considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease AT mcclementslana considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease AT gentilecarmine considerationstomodelheartdiseaseinwomenwithpreeclampsiaandcardiovasculardisease |